Doximity, Inc. (DOCS) company profile
Close on Nov 11, 2026Market cap $5.92BP/E 46.1Yield –
About Doximity
Services-Computer Programming Services, SIC 7371
Doximity operates a digital platform tailored for medical professionals, offering tools that support clinical productivity, career management, and collaboration. Its core commercial offerings are organized into Marketing Solutions, Hiring Solutions, and Workflow Solutions. Through Marketing Solutions, pharmaceutical manufacturers and health systems share sponsored content with targeted clinicians. Hiring Solutions delivers digital recruitment capabilities and personalized staffing via Curative Talent. Workflow Solutions features the Clinical AI Suite—including the Ask clinical AI assistant, Scribe ambient documentation, and Dialer telehealth—alongside digital fax, secure messaging, and on-call scheduling tools.
The platform serves more than three million registered members across all 50 U.S. states and every medical specialty, encompassing over 85% of domestic physicians, two-thirds of nurse practitioners and physician assistants, and roughly 90% of graduating medical students. Additionally, more than 140 leading U.S. health systems deploy its Clinical AI Suite. The provided text details operations across the United States but does not state the company's headquarters location.
Summary of the business section of Doximity's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Doximity, Inc.
- Founded
- 2011
- Headquarters
- San Francisco, CA
- Address
- 500 Third Street, Suite 510 94107
- Phone
- (650) 549-4330
- Website
- www.doximity.com
- Employees
- 880, Mar 31, 2026
- Industry
- Services-Computer Programming Services
- Incorporated in
- Delaware
- Fiscal year ends
- March 31
- Auditor
- Deloitte & Touche LLP, San Francisco, California
Stock & identifiers
- Ticker
- DOCS
- Exchange
- NYSE
- IPO date
- Jun 25, 2021
- Shares outstanding
- 178M, Jul 30, 2026
- Public float
- $9.86B, Sep 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1516513
- CUSIP
- 26622P107
- ISIN
- US26622P1075
- FIGI
- BBG0026ZJQX7
- Share class FIGI
- BBG0026ZJQY6
- EIN
- 27-2485512
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Jeffrey Tangney | Chief Executive Officer, Director | 50,656,951 |
| Siddharth Sitaram | Chief Accounting Officer | 101,432 |
| Steven L. Zatz | President | 100,791 |
| Matthew Sonefeldt | Chief Financial Officer | 486,238 |
| Anna Bryson | Chief Financial Officer | 516,930 |
| Timothy S. Cabral | Director | 8,084 |
| Kira Scherer Wampler | Director | 27,923 |
| Watkin Phoebe L. Yang | Director | 24,744 |
| Regina M. Benjamin | Director | 58,987 |
| Kevin Spain | Director | 3,055,024 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2026 | $19.59M | -$34.13M | $2.17M | $44 | $210 |
| FY2025 | $17.23M | $84.83M | $1.33M | $109 | $162 |
| FY2024 | $298.87K | -$15.68M | $2.49M | $51 | $153 |
| FY2023 | $243.73K | -$101.69M | $1.07M | $61 | $105 |
| FY2022 | $243.39K | $217.52M | $3.23M | $98 | $110 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2026
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Jeff Tangney Chief Executive Officer | $627.00K | $18.96M | – | $3.27K | $19.59M | +14% |
| Anna Bryson Former Chief Financial Officer | $369.79K | $2.00M | $176.62K | $2.67K | $2.55M | +209% |
| Sid Sitaram Chief Accounting Officer | $328.33K | $512.03K | $70.00K | $7.32K | $917.68K | – |
| John T. Vaughan General Counsel | $225.38K | $3.21M | – | $6.18K | $3.45M | – |
| Jennifer Chaloemtiarana Former General Counsel | $218.78K | $1.23M | – | $325.86K | $1.78M | +8% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Jun 25, 2021
- Offer price
- $26.00
- Securities offered
- 23,300,000
- Gross proceeds
- $605.80M
- Exchange
- NYSE
- First trading day
- Jun 24, 2021
- First-day close
- $53.00+103.8%
- Lock-up ends (est.)
- Dec 21, 2021
“The initial public offering price is $26.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of March 31, 2026, we had a total of 880 full-time equivalent employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jun 25, 2021 | IPO | Initial public offering priced (424B4 prospectus) |
| Jun 15, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?